Breast cancer treatments impact work status

	Tweet

Among working women with newly diagnosed breast cancer, those treated with chemotherapy appear more likely to experience a major change in work status, study findings suggest.

By contrast, radiation therapy was not associated with a similar risk, Dr. Michael J. Hassett, at Dana-Farber Cancer Institute in Boston, and colleagues report in the journal Cancer.

Hassett’s team used a large health insurance claim database to identify 3233 insured women, younger than 64 years old, who were working full or part time when first diagnosed with breast cancer between 1998 and 2002.

Overall, about 54 percent underwent chemotherapy and 58 percent underwent radiation therapy.

Most of the women did “not experience a significant change in their employment after cancer diagnosis and treatment,” Hassett told Reuters Health.

However, of the 6.6 percent who did have a change in work status, those receiving chemotherapy had 1.8-fold greater risk of leaving work, retiring, or going on long-term disability over the subsequent year, he and colleagues found.

Of the women who experienced a change in employment during the year after their diagnosis, 67 percent went from full-time work to early retirement. The rest went from full-time employment to long-term disability, retirement, or their status was unknown.

When the investigators allowed for factors associated with employment status, such as type of breast cancer, treatment, and health insurance plan, plus region, age, and other medical conditions, only chemotherapy treatment and older age were associated with greater risk of a change in employment.

“Most of the women in our study worked for large employers that sponsored health insurance programs for their employees,” Hassett added. He and colleagues call for further investigations to assess the impact cancer diagnosis and treatments have on women who work for smaller companies or are self-employed.

SOURCE: Cancer, June 15, 2009.

RELATED STORIES:
Smoking Did Not Influence Breast Cancer Risk Among Obese Women   Osteo Drug Stops Bone Loss From Breast Cancer Chemo   Glaxo drug slows breast cancer in study   Childhood Cancer Survivors Show Inadequate Screening for Breast Cancer   Study Shows Chemotherapy Improves Survival Among Older Breast Cancer Patients   Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients   New Treatment Tested for Common Type of Non-Invasive Breast Cancer   Study finds mammography screening reduces breast cancer mortality   Obese Patients with HER2-Positive Breast Cancer May Have Worse Outcomes   Breast cancer treatment offers better outcome to women with implants   New Breast Cancer Treatment Shows Promise in Early Application   New Subtype of Breast Cancer Responds to Targeted Drug   Manchester researchers announce new methods of beating breast cancer   FDA Panel OKs Ultrasound to Screen Dense Breasts   Molecules can block breast cancer’s ability to spread   Early Xeloda does not help in breast cancer- study   Seven quality guidelines for breast, colorectal cancer care   Researchers Finding New Ways to Prevent, Diagnose and Treat Breast Cancer   Mushrooms, green tea may lower breast cancer risk   African-American women with advanced breast cancer often forego vital treatment   Chemotherapy may not affect memory in breast cancer patients   Mammograms on the rise for foreign-born women living in the US

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]